Female mice of B6AF1
It is generally accepted that the recent increase in the incidence of cervical and vaginal adenocarcin.oma in offspring when they reach the adult stage is intimately related to prenatal exposure to exogenous estrogens administered to their mothers during pregnancy (Herbst, 1976) . On the other hand, persistent hyperplasia and keratinization of the vaginal epithelium are induced by the perinatal exposure to high doses of estrogen or androgen in female mice. The changes produced are ovary independent as evidenced by the persistence of these states and the progressive development to vaginal and cervical tumors after ovariectomy (see Takasugi, 1976, for review) .
In this respect, neonatal mouse will serve as a human model for the investigation of the long-term effects of perinatal hormone exposure on the reproductive tract (Bern et al., 1976) .
Recently Bern (1977, 1979) , reported adenosis-like lesions and other cervicovaginal abnormalities in mice given estrogen plus progesterone neonatally, which, appeared more frequently in non-overiectomized than in ovariectomized mice. Kimura and Nandi (1967) have shown that the incidence of lesions was lowered by ovariectomy. In the light of these findings, our attention was focused on the possible tumor promoting effect of the secondary estrogen treatment in neonatally estrogenized mice. (Table 1) . At autopsy, the cervicovaginal tract, uteri, adrenals and ovaries (in non-ovariectomized mice) were fixed in Bouin's fluid. Paraffin sections of the vaginal tracts were cut parasagitally into 7 tern thicknesses and stained with Delafield's hematoxylin and eosin. Other tissues were similarly processed for histological observations.
Statistics
The statistical comparison of incidence in the two groups was performed by y2 test or Fisher's exact probability test. Experimental groups were sometimes combined for convenience when there were no significant differences among groups.
Results

Vaginal smears
Initial changes in the vaginal epithelium were studied by examining vaginal smears at intervals. Persistent vaginal cornification (PVC) was observed in almost all (more than 95%) neonatally estrogenized mice at about 40 days of age (Groups 1-4). Ovariectomy at 40 days of age did not greatly affect the incidence of PVC. The incidence at 70-80 days of age in ovariectomized mice (Groups 3 and 4) was 83% and that in non-ovariectomized mice (Groups 1 and 2) was 91 %. Implantation of the estradiol pellet in neonatally estrogenized mice induced PVC in 100% of the animals immediately after the operation and this u : adenosis-like structure mixed with some squamous lesions near urethral orifice. ** Difference between incidence of cornification regardless of age at autopsy in Group 7 and in Group 8 is significant (P < 0.05, x2 cal= 4.63). *** Difference between incidence of vaginal lesions (s , a or u) in neonatally estrogenized mice killed at the age of 16-21 m and in those at 24-32 m is significant (P < 0.01, Fisher's exact probability test).
continued for some time after the removal of pellet. However, the PVC incidence decreased at about 360 days of age regardless of whether ovariectomy and secondary estrogen treatment (PVC incidence in combined Groups 1-4 was 63%) had taken place or not. Thereafter PVC incidence was further reduced in neonatally estrogenized animals (Groups 1-4), being 45% at the age of about 480 days and 53% at more than 720 days.
In ovariectomized control mice, implantation of the estradiol pellet (Group 8) induced cornification in all of them which continued until the removal of pellet. In non-ovariectomized mice estradiol implantation (Group 6) resulted in mucification of the vaginal epithelium in about half, possibly indicating the secretion of progesterone. However, after removal of the pellet the groups of mice. The vaginal epithelium of the control ovariectomized mice showed cornification in 56% of the total number of animals. However, the incidence of cornification was significantly greater in mice given an estradiol pellet (Group 8) than in those given no pellet (Group 7). Mucification was encountered in 6 of 27 ovariectomized mice (Groups 7 and 8) and in 2 of 32 nonovariectomized mice (Groups 5 and 6).
Hyperplastic lesions in the vagina and cervix were found in mice of Groups 1-3 receiving neonatal estrogen treatment (Table  2 ). In Group 4 mice, however, lesions were not found in any of the 17 mice. There was no significant difference between the incidence of lesions in neonatally estrogenized mice given secondary estrogen treatment and that in those receiving no secondary treatment.
The lesions ranged histologically from those resembling squamous cell carcinomas to adenosis-like structures ( Figs. 1 and 2 ). The development of lesions was significantly more pronounced in neonatally estrogenized mice killed at 24-32 months of age than in those at 16-21 months. In most neonatally estrogen.ized mice, the urethra was observed to open in the vaginal lumen, and on the nearby vaginal wall sometimes squamous and adenosis-like lesions developed. Downgrowths were frequently encountered in the proximal and distal vagina and at the cervix.
In vehicle control mice no vaginal lesions were observed, except that one 
Uterus and ovary
The uterine epithelial cells were hypertrophied in 13 of 21 neonatally estrogenized non-ovariectomized mice at 16-21 months old, but the ratio decreased to 1/10 at 24-32 months.
The uterine epithelium in ovariectomized neonatally estrogenized mice was mostly atrophic in either age period. However, regardless of whether ovariectomy had been performed or not, squamous metaplasia was encountered in all groups of neonatally estrogenized mice.
The uterine epithelial cells were hypertrophied in 10 of the 15 control nonovariectomized mice (Groups 5 and 6) at 16-21 months of age, and in 3 of 16 mice at 24-32 months of age. The ovariectomized control mice (Groups 7 and 8) also showed hypertrophy of the epithelial cells in 8 of 14 mice at 16-21 months of age and 2 of 12 mice at 24-32 months. The uterine glands became prominent in most ovariectomized control mice and the glandular lumen was markedly dilated.
The ovaries of neonatally estrogenized mice invariably contained hypertrophied interstitial tissue and marked ceroid deposition but never contained corpora lutea. In control mice (Group 5) the ovaries contained corpora lutea in 6 of 11 mice at the age of 16-21 months but only in 1 of 12 mice at 24-32 months (p<0.05, Fisher's exact probability test). Ceroid deposition was also marked in these ovaries, particularly in the central interstitial tissue.
Adrenal
In non-ovariectomized mice, the histological appearance of the adrenal was essentially normal in both control and estrogenized mice. In contrast to this, in the ovariectomized control mice the adrenals showed distinct abnormalities.
Twelve out of 15 control ovariectomized mice at 16-21 months of age (Groups 7 and 8) had nodules in at least one of their adrenals. The nodules consist mainly of B type cells of Woolly (1950) which have characteristic clear cytoplasm and resemble lutein cells. There was a certain parallelism between the presence of adrenal nodules and the hypertrophy of uterine epithelial cells in ovariectomized mice. From the outer surface, a palisade-like invasion of the spindle-shaped cells was observed in some adrenals. The development of nodules was significantly less in neonatally estrogenized mice (1/13, Group 3) than in control ovariectomized mice (8/13, Group 7) (p< 0.02, Fisher's exact probability test).
Discussion
Neonatal administration of estrogen or androgen gave rise to a high incidence of persistent vaginal cornification and hyperplastic epithelial lesions which are not abolished by ovariectomy (Takasugi, 1976) . The findings in the present long-term studies on the final outcome of the hyperplastic vaginal and cervical epithelium until around 2.5 years of age are generally consistent with those of previous investigators. However, the incidence of lesions was lower than those reported by Bern (1977, 1979) and by Jones and PacillasVerjan (1979) in BALB/C mice. Although there is a strain difference, the possibility that mice bearing lesions had died during the present experimental period was not ruled out. If this is not the case, B6AF1 hybrids may be more resistant to neonatal estrogen treatment than BALB/C mice.
Our major concern in the present experiments has been the question of whether secondary estrogen treatment may have ay tumor promoting effects on exsisting cervicovaginal lesions. The significant role of estrogen in adults has been suggested by previous investigators on the basis of the effects of ovariectomy (Kimura and Nandi, 1967; Bern, 1977, 1979) . However, we could not obtain any evidence to support this suggestion by inducing early or more frequent development of lesions in neonatally estrogenized mice. One of the possible explanations of the ineffectiveness of secondary estrogen treatment relates to the changes in sensitivity to exogenous steroids. Mori (1969 Mori ( , 1975 and Iguchi (1977) reported that in neonatally estrogenized or androgenized vaginae estrogen was less likely to increase mitotic activity. A reduction in sensitivity to estrogen was also demonstrated by comparing the amount of material stored in the lumina of the transplanted vagina (Takasugi and Kimura, 1967) . Ohta and Iguchi (1976) reached a similar conclusion on the basis of the reponse of the vagina to progesterone plus estrogen in inducing mucification.
Estrogen binding capacity (Terenius et al., 1969) and nuclear estrogen receptors (Shyamala et al., 1974) of these vaginae were notably decreased.
Another possible explanation comes from the observation by Mori (1976) that the latent normal cells along the basal lamina responded to secondary estrogen treatment and proliferated. Therefore, if the proliferation of 'normal' cells causes shedding of the abnormal cells (B cells of Takasugi, 1971 ) from the vaginal epithelium to some extent, it is possible that no lesion promoting effect of the secondary estrogen treatment will be observed.
As the source of estrogenic and progestational substances in ovariectomized control mice showing vaginal cornification or mucification and transformation of the glandular lumen, adrenals are the most probable candidate, because it has been suggested that the adrenals in female mice secrete both estrogen and androgen several months after ovariectomy under the influence of increased circulating gonadotropins (Rosner et al., 1966 ; Pierman, 1967) . Nodular hyperplasia, adenoma, or carcinoma usually occurs in the adrenal cortex after ovariectomy (Takasugi et al., 1975) . In the present experiments the nodular hyperplasia of the adrenal in neonatally estrogenized ovariectomized mice was less marked than in control ovariectomized mice. A cervicovaginal lesion was found in only one animal out of 27 control ovariectomized mice. These findings indicated that steroid hormones secreted from the hyperplastic adrenals are neither capable of inducing cervicovaginal lesions in control mice nor playing any important role in aggravating the lesions in neonatally estrogenized mice.
In conclusion, the results reported herein indicate that hyperplastic lesions in the cervicovaginal tract were present in neonatally estrogenized mice but they were not enhanced by secondary estrogen administration in the form of a pellet. It is clear that neonatal exposure to high doses of estrogen was of primary importance in connection with the neoplastic changes in the cervicovagin al tract.
